Tributes paid to cancer scientist who tried experimental treatment
Richard Scolyer dies aged 59 after undergoing world-first treatment for his brain tumour
Search
-
-
New value for money rules ‘disproportionate’, say universities
Proposed regulatory conditions are ‘too broad’, lack clear guidance and will increase burden on institutions, say sector groups
-
Can peace studies thrive in the era of ‘strongmen’ leaders?
With thousands dying in armed conflicts across the world, peace studies may hold valuable insights on ending war. But suspicions over the discipline’s innovative theories mean its voice has not...
-
New Danish government rows back on controversial master’s reforms
Academics welcome coalition’s commitment to expanding STEM places, but warn hard-hit humanities subjects have been ‘hardly’ mentioned
-
Colleagues should not be cancelled for examining ‘enemy perspectives’
Academic debates should embrace political neutrality, professional judgement and the plurality of possible interpretations. The campaign against Ivan Katchanovski does not, say Dmitry Dubrovskiy and...
-
UKRI’s three-day research grant call ‘unfair on applicants’
Rush to ‘get funding out of door’ after delayed budget settlement will harm quality of submissions and staff well-being, warns ex-UKRI director
-
Can pensioners bring back buzz to university life?
Developers behind ‘university retirement communities’ believe the model can benefit pensioners, students and institutional finances